Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Noxopharm Ltd
NOXCurrent price
0.11 AUD
0 AUD (0.00%)
Last closed
0.11 AUD
Company
www.noxopharm.com
ISIN
AU000000NOX9
Sector
Healthcare
Industry
Biotechnology
Exchange
Australian Securities Exchange
Capitalization
30 788 125 AUD
Yield for 12 month
-19.23 %
1Y
3Y
5Y
10Y
15Y
NOX
Noxopharm Limited, a biotech company, engages in the discovering and developing treatments for cancer and inflammation, and mRNA vaccines in Australia. It develops Sofra, a platform that focuses on the development of immunomodulators for mRNA vaccines and mRNA therapeutics, as well as for the treatment of autoimmune diseases; and Chroma technology platform to develop CRO-67 dual-cell therapy drug for the treatment of pancreatic cancer and various molecules for the treatment of autoimmune disease and hyperinflammatory conditions. The company also develops orphan drug designations to treat less common disease; and IONIC program with Veyonda, which is combined with the Bristol Myers Squibb checkpoint inhibitor Opdivo for the treatment of various solid tumor types. Noxopharm Limited was incorporated in 2015 and is based in Glenhaven, Australia. Address: 60 Linksley Avenue, Glenhaven, NSW, Australia, 2156
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1.53 AUDP/E ratio
–Dividend Yield
–Current Year
+2 408 344 AUD
Last Year
+6 030 286 AUD
Current Quarter
+1 192 312 AUD
Last Quarter
+1 216 032 AUD
Current Year
-536 608 AUD
Last Year
+5 875 233 AUD
Current Quarter
-296 747 AUD
Last Quarter
+1 215 152 AUD
Key Figures NOX
1 year
3 years
5 years
10 years
EBITDA
-4 615 376 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-34.01 %
PEG Ratio
–
Return On Equity TTM
-49.12 %
Wall Street Target Price
1.53 AUD
Revenue TTM
2 408 344 AUD
Book Value
0.019 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-55.4 %
Dividend Yield
–
Gross Profit TTM
-4 652 082 AUD
Earnings per share
-0.01 AUD
Diluted Eps TTM
-0.01 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-149.07 %
Dividend Analytics NOX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NOX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation NOX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
12.7839
Enterprise Value EBITDA
-1.1582
Price Book MRQ
5.584
Financials NOX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NOX
For 52 weeks
0.051 AUD
0.15 AUD
50 Day MA
0.11 AUD
Shares Short Prior Month
–
200 Day MA
0.083 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart